home / stock / abvc / abvc quote
Last: | $4.95 |
---|---|
Change Percent: | 0.2% |
Open: | $4.85 |
Close: | $4.95 |
High: | $4.95 |
Low: | $4 |
Volume: | 5,101 |
Last Trade Date Time: | 08/02/2021 04:40:25 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.95 | $4.85 | $4.95 | $4.95 | $4 | 5,101 | 08-02-2021 |
$4.94 | $4.85 | $4.94 | $4.99 | $4.85 | 571 | 07-30-2021 |
$4.4 | $4.9 | $4.4 | $5.1 | $4.4 | 1,220 | 07-29-2021 |
$4.7 | $5 | $4.7 | $5.1 | $4.7 | 700 | 07-28-2021 |
$5 | $5 | $5 | $5 | $5 | 506 | 07-27-2021 |
$5 | $4.95 | $5 | $5 | $4.95 | 700 | 07-26-2021 |
$4.95 | $4.95 | $4.95 | $4.95 | $4.95 | 751 | 07-23-2021 |
$5 | $4.95 | $5 | $5 | $4.95 | 606 | 07-22-2021 |
$4.95 | $4.9 | $4.95 | $4.95 | $4.9 | 1,000 | 07-21-2021 |
$5 | $4.95 | $5 | $5 | $4.95 | 1,100 | 07-20-2021 |
$5 | $4.95 | $5 | $5 | $4.95 | 1,000 | 07-19-2021 |
$5 | $4.95 | $5 | $5 | $4.95 | 1,000 | 07-16-2021 |
$4.95 | $4.95 | $4.95 | $4.95 | $4.95 | 400 | 07-15-2021 |
$5 | $4.95 | $5 | $5 | $4.95 | 801 | 07-14-2021 |
$4.95 | $4.9 | $4.95 | $4.95 | $4.9 | 600 | 07-13-2021 |
$4.95 | $4.9 | $4.95 | $4.95 | $4.9 | 749 | 07-12-2021 |
$5 | $5 | $5 | $5 | $5 | 400 | 07-09-2021 |
$5 | $5 | $5 | $5 | $5 | 400 | 07-08-2021 |
$5 | $5 | $5 | $5 | $5 | 600 | 07-07-2021 |
$5 | $4.9 | $5 | $5 | $4.8 | 900 | 07-06-2021 |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc. and AiBtl BioPharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will i...
FREMONT, CA - ( NewMediaWire ) - July 9, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that after successful Phase II c...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...